TAK
Takeda Pharmaceutical Company Limited
NYSE Healthcare
16,89 $US
+0.72% today
+8.13% YTD · +12.08% 1Y
28
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
16
Hedge funds tracked
200+ 13F SEC funds, updated quarterly
16
Thematic ETFs
ARK, NANC, GOP, GURU, BUZZ, JEPI, ITA…
24h
Frequency
Daily 5AM UTC pipeline · 2-year historical DB
64
/ 100
STRONG

Kairos Score: 64/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enan...

Key info

🎂
Founded
1781
👥
Employees
47 029
💰
Market cap
53 691 142 216,00 $US
📊
P/E
44.3
💸
Dividend yield
0.03%

🕴️ Insider activity (90 days)

28 transactions — including 0 buys declared by Takeda Pharmaceutical Company Limited executives to SEC / AMF / BaFin.

GS
GILLIS STEVEN
2026-07-01
Other
IM
Iijima Masami
2026-07-01
Other
MA
Miyabashira Asuka
President, Japan Pharma B.U. · 2026-07-01
Other

🏦 Hedge Funds

16 institutional funds report a position on TAK in their latest SEC quarterly filing.

Capital Research Global Investors
TIAA CREF INVESTMENT MANAGEMENT LLC
FMR LLC
MORGAN STANLEY
ADAGE CAPITAL PARTNERS GP, L.L.C.

📰 Recent news

15 recent articles on TAK.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Automatic detection when 3+ executives buy the same stock simultaneously — historically the most reliable signal.

🏦

13F Hedge Funds

Berkshire (Buffett), Pershing Square (Ackman), Tiger Global, Bridgewater + 200 more. Who buys what, each quarter.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot small caps whose retail interest explodes before the rest of the market. 100+ tickers monitored.

📧

Email alerts

Create your watchlist and receive every morning at 8am the Brief of events on YOUR tickers.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of TAK on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 28 insider transactions over 90 days
✅ All 16 hedge funds (among 200+ tracked)
✅ 11 thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ 2-year history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + 6-quarter earnings
See full analysis →
Analyze other tickers for free →

Free signup · Premium €29/month no commitment